Jihan Khan

Title: Jihan Khan: Innovator in Gastrointestinal Treatments

Introduction

Jihan Khan is a notable inventor based in Somerville, MA (US), recognized for his contributions to the field of pharmaceutical sciences. He holds a patent that focuses on innovative compounds and methods for treating gastrointestinal microbial infections in mammals. His work is significant in the ongoing battle against parasitic and bacterial infections.

Latest Patents

Jihan Khan's patent, titled "Compounds and methods for treating mammalian gastrointestinal microbial infections," describes compounds and their pharmaceutically acceptable salts and prodrugs that serve as inhibitors of IMPDH. The invention highlights the selective inhibition of parasitic IMPDH compared to host IMPDH, which is crucial for developing targeted therapies. Additionally, the patent outlines pharmaceutical compositions that incorporate these compounds, as well as methods for treating various infections in mammals. The compounds may be utilized alone or in conjunction with other therapeutic agents, including anti-virals, anti-inflammatory agents, antimicrobials, and immunosuppressants.

Career Highlights

Throughout his career, Jihan Khan has worked with esteemed institutions such as Brandeis University and the University of Georgia Research Foundation, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Jihan has collaborated with notable colleagues, including Lizbeth K Hedstrom and Gregory D Cuny. These partnerships have likely enriched his research and innovation efforts.

Conclusion

Jihan Khan's work in developing compounds for treating gastrointestinal infections showcases his commitment to advancing medical science. His innovative approaches have the potential to significantly impact the treatment of microbial infections in mammals.